(1α,2β,4β,5α,7β)-()-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate hydrochloride (672-21-9)
Identification |
Properties |
Safety Data |
|
|
Other Product
- [7(S)-(1α,2β,4β,5α,7β)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate
- 5-oxo-L-proline, compound with [7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl α-(hydroxymethyl)benzeneacetate (1:1)
- (1α,2β,4β,6α)-()-2,2,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane
- (1α,3aβ,4α,7α,8aβ)-hexahydro-1,4,10,10-tetramethyl-1H,4H,3a,8a-epoxy-4,7-methanoazulene
- (4α,8α,9β,13α,14β,17Z)-16β-acetoxy-3α,11α-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, compound with 2,2'-iminodiethanol (1:1)
- methyl [3S-(3α,4β,21β]-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-9-vinylphorbine-3-propionate
- Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3aα,4β,5α,6α,8β,9α,9aβ,10S*)]-, (E)-2-butenedioate (2:1)
- Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3aα,4β,5α,6α,8β,9α,9aβ,10S*)]-, (E)-2-butenedioate, comp
- (1α,3α,4α,5β)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid, compound with 4-hydroxy-α-[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]benzenemethanol (1:1)
- [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with α-phenylbenzylamine
- Acetic acid, [(6-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamid
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2α,5α,6β)]-, compd. with [R-(R*,S*)]-β-(methylamino)-α-phenylbenzeneethanol (1:1)
- (2α,3aβ,5α,6β,6aβ)]-hexahydro-4-methyl-2,5-methano-2H-furo[3,2-b]pyrrol-6-ol hydrobromide
- 5-Heptenoic acid, 7-[3,5-dihydroxy-2-[2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]-, [1R-[1α(Z),2β(E),3α,5α]]-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
- bis[N-[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl]glycinato]copper
- [3S-(3α,4β,21β]-21-carboxy-14-ethyl-4,8,13,18-tetramethyl-20-oxo-9-vinylphorbine-3-propionic acid
- disodium [3S(3α,4β,21β)]-21-carboxy-14-ethyl-4,8,13,18-tetramethyl-20-oxo-9-vinylphorbine-3-propionate
- sodium [3S-(3α,4β,21β)]-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-9-vinylphorbine-3-propionate
- potassium [3S(3α,4β,21β)]-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-9-vinylphorbine-3-propionate
- ()(1α,2β,5β)-5-methyl-2-(1-methylethyl)cyclohexyl salicylate